天然产物研究与开发 ›› 2023, Vol. 35 ›› Issue (11): 1977-1990.doi: 10.16333/j.1001-6880.2023.11.016

• 数据研究 • 上一篇    下一篇

基于网络药理学和实验验证探讨海巴戟抗动脉粥样硬化的作用机制

张   哲1,王   蓓2,唐根云3,饶利兵3,林   玲2*   

  1. 1广州医科大学研究生院,广州 510000;2三亚中心医院(海南省第三人民医院),三亚 572000;3湖南医药学院,怀化 418000
  • 出版日期:2023-11-28 发布日期:2023-11-26
  • 基金资助:
    海南省自然科学基金(821QN432)

Mechanism of Morinda citrifolia against atherosclerosis based on network pharmacology and experiment verification

ZHANG Zhe1,WANG Bei2,TANG Gen-yun3,RAO Li-bing3,LIN Ling2*   

  1. 1Graduate School of Guangzhou Medical University,Guangzhou 510000,China;2Sanya Central Hospital (Hainan Third People′s Hospital),Sanya 572000,China;3Hunan University of Medicine,Huaihua 418000,China
  • Online:2023-11-28 Published:2023-11-26

摘要:

运用网络药理学探究海巴戟治疗动脉粥样硬化(atherosclerosis,AS)的机制及实验验证研究。利用CMAUP、TCMSP、SwissADME数据库检索并筛选海巴戟的活性成分,分别在GeneCards、OMIM、TTD、PharmGKB及Drugbank数据库中设置筛选条件检索去重后得到AS靶点。通过STRING数据库构建蛋白互作网络(PPI),采用R语言对交集靶点进行GO和KEGG富集分析。构建THP-1源性巨噬细胞模型进行体外实验验证,通过CCK-8实验筛选海巴戟给药浓度,采用油红O染色和22-NBD-Cholesterol细胞荧光方法检测海巴戟干预后模型细胞内胆固醇含量的变化,再使用RT-PCR、WB实验检测和验证所预测的信号通路。结果显示从海巴戟中共筛选出活性成分59个,靶点332个,参与治疗AS的交集靶点154个,包括PPARG、MMP9、IL-6、CCL2等;GO富集分析得到2 844个条目,前10个条目主要包括调节细胞膜受体与核受体等生物学功能,KEGG富集分析得到182个条目,前20个条目主要包括脂质代谢与动脉粥样硬化、过氧化物酶体增殖物激活受体(PPAR)信号通路等。在验证实验中,首先利用CCK-8实验筛选出了合适的海巴戟浓度(10、20、40 μg/mL),油红O染色和22-NBD-Cholesterol细胞荧光结果显示海巴戟可促进THP-1源性巨噬细胞内胆固醇流出,且呈剂量依赖性;RT-PCR、WB结果显示海巴戟可激活PPARγ信号通路,增加PPARγ和ATP结合盒转运蛋白A1(ABCA1)的表达。GW9662阻断PPARγ信号通路后海巴戟促进THP-1源性巨噬细胞内胆固醇的流出能力下降,且PPARγ和ABCA1表达随之下调。因此,运用网络药理学结合实验验证揭示海巴戟可能通过激活PPARγ信号通路促进THP-1源性巨噬细胞胆固醇的流出而改善AS。

关键词: 海巴戟, 网络药理学, 过氧化物酶体增殖物激活受体γ, 胆固醇逆转运, 动脉粥样硬化

Abstract:

To investigate the mechanism and experimental verification of Morinda citrifolia in the treatment of atherosclerosis (AS) via network pharmacology.CMAUP,TCMSP and SwissADME databases were used to search and screen the active ingredients of M. citrifolia.The AS targets were obtained after setting screening conditions in GeneCards,OMIM,TTD,PharmGKB and Drugbank databases.The protein interaction network (PPI) was constructed using STRING database,and the GO function enrichment analysis and KEGG pathway analysis for intersection targets were performed using R language.The THP-1-derived macrophage model was constructed for in vitro experiment verification.The concentration of M. citrifolia was screened by CCK-8 assay.Oil red O staining and 22-NBD-Cholesterol fluorescence assay were used to detect the intracellular cholesterol in the model cells following the treatment of M. citrifolia.A total of 59 active ingredients,332 targets and 154 targets associated with AS,such as PPARG,MMP9,IL-6 and CCL2,were screened from M. citrifolia.GO function enrichment analysis obtained 2 844 items,and the top 10 items mainly included biological functions such as regulating cell membrane receptors and nuclear receptors.KEGG pathway analysis obtained 182 items,which of the top 20 items primarily contained lipid metabolism and atherosclerosis,peroxisome proliferator-activated receptor (PPAR) signaling pathway,etc.In vitro experiments were performed to validate the appropriate concentration of M. citrifolia (10,20,40 μg/mL) screened by CCK-8 assay firstly.Oil red O staining and 22-NBD-Cholesterol cell fluorescence found that M. citrifolia promoted cholesterol efflux of THP-1-derived macrophages in a dose-dependent manner.Subsequently,RT-PCR and WB assays showed that M. citrifolia activated PPARγ signaling pathway and increased the expression of PPARγ and ATP-binding cassette transporter A1 (ABCA1) significantly.The capability of M. citrifolia to promote cholesterol efflux in THP-1-derived macrophages was decreased dramatically,and the levels of PPARγ and ABCA1 were down-regulated after blunting PPARγ signaling pathway by GW9662,PPARγ inhibitor.Therefore,network pharmacoloty combined with experimental validation in vitro indicated that M. citrifolia could ameliorate atherosclerosis by promoting cholesterol efflux from THP-1-derived macrophages via PPARγ signaling pathway.

Key words: Morinda citrifolia, network pharmacology, PPARγ, reverse cholesterol transport, atherosclerosis

中图分类号:  285.5